Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case report: CD19-directed CAR-T cell therapy combined with BTK inhibitor and PD-1 antibody against secondary central nervous system lymphoma. | Front Immunol | 2022 | 36275715 | PubTator, text mining | PubMed |
| Costimulators expressed on human endothelial cells modulate antigen-dependent recruitment of circulating T lymphocytes. | Front Immunol | 2022 | 36275645 | PubTator, text mining | PubMed |
| Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration. | J Inflamm Res | 2022 | 36274829 | PubTator, text mining | PubMed |
| A Novel Risk Model for lncRNAs Associated with Oxidative Stress Predicts Prognosis of Bladder Cancer. | J Oncol | 2022 | 36268283 | PubTator, text mining | PubMed |
| Identification of fatty acid signature to predict prognosis and guide clinical therapy in patients with ovarian cancer. | Front Oncol | 2022 | 36267966 | PubTator, text mining | PubMed |
| Expression Profiles of Differentially Expressed Circular RNAs and circRNA-miRNA-mRNA Regulatory Networks in SH-SY5Y Cells Infected with Coxsackievirus B5. | Int J Genomics | 2022 | 36267594 | PubTator, text mining | PubMed |
| A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma. | Front Genet | 2022 | 36267408 | PubTator, text mining | PubMed |
| Multiple Sclerosis CSF Is Enriched With Follicular T Cells Displaying a Th1/Eomes Signature. | Neurol Neuroimmunol Neuroinflamm | 2022 | 36266053 | PubTator, text mining | PubMed |
| Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma. | PLoS One | 2022 | 36264920 | PubTator, text mining | PubMed |
| A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients. | Hereditas | 2022 | 36253800 | PubTator, text mining | PubMed |
| Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis. | J Clin Invest | 2022 | 36250467 | PubTator, text mining | PubMed |
| Congenital Herpes Simplex Virus: A Histopathological View of the Placenta. | Cureus | 2022 | 36249599 | PubTator, text mining | PubMed |
| Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: Assessing its role in tumor prognosis and immune response. | Front Oncol | 2022 | 36248971 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR/BCR clonal expansion in a relapsed ovarian cancer patient. | Front Immunol | 2022 | 36248860 | PubTator, text mining | PubMed |
| Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma. | Front Immunol | 2022 | 36248822 | PubTator, text mining | PubMed |
| Identification and validation of a 17-gene signature to improve the survival prediction of gliomas. | Front Immunol | 2022 | 36248799 | PubTator, text mining | PubMed |
| Integration of three machine learning algorithms identifies characteristic RNA binding proteins linked with diagnosis, immunity and pyroptosis of IgA nephropathy. | Front Genet | 2022 | 36246620 | PubTator, text mining | PubMed |
| Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer. | Front Genet | 2022 | 36246597 | PubTator, text mining | PubMed |
| Selective immunocapture reveals neoplastic human mast cells secrete distinct microvesicle- and exosome-like populations of KIT-containing extracellular vesicles. | J Extracell Vesicles | 2022 | 36239715 | PubTator, text mining | PubMed |
| Virus-Associated Nephropathies: A Narrative Review. | Int J Mol Sci | 2022 | 36233315 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=48